Suppr超能文献

稀释蝰蛇毒时间试验在服用华法林患者中的临床应用价值。

Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

作者信息

Kanouchi Kazunori, Narimatsu Hiroto, Ohnuma Okio, Morikane Keita, Fukao Akira

机构信息

Department of Public Health, Yamagata University Graduate School of Medicine, Yamagata, Japan.

Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan.

出版信息

Int J Hematol. 2017 Aug;106(2):206-211. doi: 10.1007/s12185-017-2228-y. Epub 2017 Apr 7.

Abstract

Warfarin use often causes false-positive results in the dilute Russell viper venom time test (DRVVT). Thus, three sets of guidelines-those presented by the International Society on Haemostasis and Thrombosis (ISTH), the British Committee for Standards in Haematology (BCSH), and the Clinical and Laboratory Standards Institute (CLSI)-are advocated. We evaluated the clinical usefulness of the testing methods recommended in these three guidelines using laboratory samples. Of the 242 samples from patients using warfarin, 38 were positive for lupus anticoagulant (LA). After adding normal pooled plasma (NPP) as recommended in the ISTH, BCSH, and CLSI guidelines, the number of samples testing positive for LA decreased to 13, 18, and 19, respectively. The number of samples with inconsistent results between the activated partial thromboplastin time and mixing test, and the DRVVT following the ISTH, BCSH, and CLSI guidelines were four of 205 (1.9%), 15 of 242 (6.2%), and 17 of 242 (7.0%), respectively. In patients with an international normalized ratio (INR) ≥3.0, 11 of 37 (29.7%) and 12 of 37 (32.4%) samples showed inconsistent results according to the BCSH and CLSI guidelines, respectively. The accuracy of the DRVVT result may thus decrease in markedly anticoagulated patients.

摘要

华法林的使用常常会在稀释蝰蛇毒时间试验(DRVVT)中导致假阳性结果。因此,人们提倡遵循国际血栓与止血学会(ISTH)、英国血液学标准委员会(BCSH)以及临床和实验室标准协会(CLSI)提出的三套指南。我们使用实验室样本评估了这三套指南中推荐的检测方法的临床实用性。在242例使用华法林的患者样本中,38例狼疮抗凝物(LA)检测呈阳性。按照ISTH、BCSH和CLSI指南的建议加入正常混合血浆(NPP)后,LA检测呈阳性的样本数量分别降至13例、18例和19例。按照ISTH、BCSH和CLSI指南进行活化部分凝血活酶时间与混合试验以及DRVVT检测,结果不一致的样本数量在205例样本中有4例(1.9%),在242例样本中有15例(6.2%),在242例样本中有17例(7.0%)。在国际标准化比值(INR)≥3.0的患者中,按照BCSH和CLSI指南,分别有37例样本中的11例(29.7%)和12例(32.4%)结果不一致。因此,在抗凝作用明显的患者中,DRVVT结果的准确性可能会降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验